Literature DB >> 7509356

The acute effects of pancreaticopyelostomy on the pancreas and kidney. A preliminary study.

A Coker1, A Menteş, I Coker.   

Abstract

A modified canine pancreaticopyelostomy model with an intact kidney was constructed. The effects of this procedure on the pancreas and kidney were examined in five dogs by monitoring the serum and urine levels of pH, bicarbonate, chloride, glucose, urea, creatinine and amylase in 24-h periods for up to 72 h. The contralateral kidney served as controls. The pancreas and kidney were removed and examined under light microscopy after the animals were sacrificed. Both of the organs had maintained their normal histological architecture. The serum and urine glucose levels were consistent with a normal response after the initial elevation immediately following the surgical trauma. The urine urea concentrations from both kidneys were similar, as were the creatinine excretion trends throughout the 72 h, except for a significant rise in the creatinine excretion on the pancreaticopyelostomy side at 24 h. The pH, bicarbonate, chloride, and amylase values revealed a normal and functioning exocrine pancreas. It is concluded from this preliminary study that pancreaticopyelostomy with an intact kidney does not have acute adverse effects, either on the pancreas or on the kidney. This procedure may be an alternative method for pancreatic exocrine drainage if similar results are obtained in chronic models.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7509356     DOI: 10.1007/BF02784931

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  19 in total

1.  Operative drainage of the pancreatic duct delays functional impairment in patients with chronic pancreatitis. A prospective analysis.

Authors:  W H Nealon; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1988-09       Impact factor: 12.969

2.  Advantages and disadvantages of urinary tract diversion in clinical pancreas transplantation.

Authors:  L Fernández-Cruz; E Esmatges; J Andreu; E M Targarona; M Prieto; J M Gil-Vernet
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

3.  Pancreas function index: an early monitor of allograft rejection.

Authors:  T L Zheng; T Schang; P Soon-Shiong; N Merideth; R Lanza; D E Sutherland
Journal:  J Surg Res       Date:  1991-01       Impact factor: 2.192

4.  Pancreatic and salivary amylase/creatinine clearance ratios in normal subjects and in patients with chronic pancreatitis.

Authors:  J E Hegarty; M D O'Donnell; K F McGeeney; O Fitzgerald
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

5.  Pancreas transplantation at Mayo: III. Multidisciplinary management.

Authors:  J D Perkins; P P Frohnert; F J Service; M P Wilhelm; M R Keating; S R DiCecco; J L Johnson; S R Munn; J A Velosa
Journal:  Mayo Clin Proc       Date:  1990-04       Impact factor: 7.616

6.  Pancreas transplantation at Mayo: II. Operative and perioperative management.

Authors:  J D Perkins; G A Fromme; B J Narr; P A Southorn; C L Marsh; S R Munn; D E Engen; S Sterioff
Journal:  Mayo Clin Proc       Date:  1990-04       Impact factor: 7.616

7.  Amylase to creatine clearance ratio in renal diseases.

Authors:  A Andriulli; R Bergia; G Masoero; P Baiardi; S Pellegrino; M Tondolo
Journal:  Gastroenterology       Date:  1979-07       Impact factor: 22.682

8.  Arterial blood supply of the left lobe of the canine pancreas. II. Electromagnetic flow measurements.

Authors:  H G Gooszen; R van Schilfgaarde; J L Terpstra
Journal:  Surgery       Date:  1983-04       Impact factor: 3.982

9.  Long-term follow-up of canine segmental pancreatic autografts.

Authors:  R G Cutfield; K Polonsky; L Olson; G Kyriakides; J Miller; D H Mintz
Journal:  Diabetes       Date:  1985-02       Impact factor: 9.461

10.  Arterial blood supply of the left lobe of the canine pancreas. I. Anatomic variations relevant to segmental transplantation.

Authors:  R van Schilfgaarde; H G Gooszen; E H Overbosch; J L Terpstra
Journal:  Surgery       Date:  1983-04       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.